Respiratory infections
Guidelines session
Managing drug-resistant tuberculosis: from new guidelines to clinical practice
Clinical
ATS/ERS/IDSA/CDC MDR-TB guidelines
Aims : to present the new guidelines for multidrug-resistant (MDR)-TB; to discuss similarities and differences with the newly published World Health Organization guidelines; to discuss the best management of challenging clinical cases affected by MDR- or extensively drug-resistant-TB, including paediatric cases.
Target audience :
Clinical researcher, Critical/Intensive care physician, General practitioner, Nurse, Paediatrician, Pathologist, Patient, Physiologist, Physiotherapist, Policy maker, Radiologist, Scientist (basic, translational), Student, Thoracic surgeon, Trainee, Adult pulmonologist/Clinician
Methods :
Public health
10:45
The new ATS/ERS/IDSA/CDC guidelines for MDR-TB: rationale, methods and recommendations
G. Migliori(Varese (VA), Italy)
COI
-
Description
1
5292
11:15
Similarities and differences among existing guidelines
G. Sotgiu(Sassari, Italy)
COI
-
Description
2
5293
11:45
Research and clinical trial needs and the challenges associated with recommending pan-oral regimens: the Latin-American and African perspective
G. Perez Mendoza(Las Palmas, Spain)
COI
-
Description
3
5294
12:15
Managing difficult cases from the Russian Federation and beyond: an interactive session
S. Borisov(Moscow, Russian Federation)
COI
-
Description
4
5295
. . .
